Funding Research Through the Online Partnership to Accelerate Research (OnPAR).
OnPAR-the Online Partnership to Accelerate Research-seeks to provide a second opportunity for funding of high-quality, unfunded applications originally submitted to the National Institutes of Health and other national and international funding agencies. OnPAR will match applicable, unfunded applications with the research priorities of nongovernment organizations such as private biomedical foundations, pharmaceutical companies, venture capital funds, and other private funds. Funding organization members will review and make final funding decisions through a simple, 2-step process whereby applicants can submit public abstracts directly to OnPAR. If a member requests additional information, then, by invitation only, an applicant can submit their original unfunded application and their peer review summary statement. Advancing research discovery and drug development to improve clinical outcomes for patients afflicted with or at risk for disease is the primary goal of OnPAR. OnPAR invites the scientific community to fully participate in this new funding paradigm by submitting their National Institutes of Health public abstracts so that funding members can review and potentially support these high-quality, unfunded applications.
['Dueñas|Martin A|MA|', 'Bisceglio|Isabelle|I|']
funding research ALS, amyotrophic lateral sclerosis CDA, Confidential Disclosure Agreement COPD, chronic obstructive pulmonary disease HIV/AIDS, human immunodeficiency virus/ acquired immune deficiency syndrome NCI, National Cancer Institute NHLBI, National Heart, Lung, and Blood Institute NIAID, National Institute of Allergy and Infectious Disease NIGMS, National Institute of General Medicine Sciences NIH, National Institutes of Health NINDS, National Institute of Neurological Disorders and Stroke OnPAR, Online Partnership to Accelerate Research TB, tuberculosis grants